These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36413344)

  • 1.
    Suman SK; Mukherjee A; Pandey U; Chakraborty A; Rakshit S; Tawate M; Sarma HD
    Cancer Biother Radiopharm; 2023 Feb; 38(1):38-50. PubMed ID: 36413344
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and preliminary bioevaluation studies of
    Suman SK; Kameswaran M; Pandey U; Sarma HD; Dash A
    J Labelled Comp Radiopharm; 2019 Oct; 62(12):850-859. PubMed ID: 31461549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of
    Sharma R; Mukherjee A; Kumar A; Sarma HD
    Cancer Biother Radiopharm; 2024 Feb; 39(1):64-74. PubMed ID: 38363819
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and preclinical studies of
    Lam K; Chan C; Reilly RM
    MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging reveals trastuzumab-induced epidermal growth factor receptor downregulation in vivo.
    Ma T; Sun X; Cui L; Gao L; Wu Y; Liu H; Zhu Z; Wang F; Liu Z
    J Nucl Med; 2014 Jun; 55(6):1002-7. PubMed ID: 24732154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Evaluation of CD20 Expression Using
    Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
    J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of a
    Xu Y; Wang L; Pan D; Yu C; Mi B; Huang Q; Sheng J; Yan J; Wang X; Yang R; Yang M
    Br J Radiol; 2019 Dec; 92(1104):20190425. PubMed ID: 31593482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward Understanding the Binding Synergy of Trastuzumab and Pertuzumab to Human Epidermal Growth Factor Receptor 2.
    Sharma R; Kumbhakar M; Mukherjee A
    Mol Pharm; 2021 Dec; 18(12):4553-4563. PubMed ID: 34757737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients.
    Rathore Y; Shukla J; Laroiya I; Deep A; Lakhanpal T; Kumar R; Singh H; Bal A; Singh G; Gopal Thakur K; Mittal BR
    Nucl Med Commun; 2022 Apr; 43(4):458-467. PubMed ID: 35131966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
    J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.
    Beylergil V; Morris PG; Smith-Jones PM; Modi S; Solit D; Hudis CA; Lu Y; O'Donoghue J; Lyashchenko SK; Carrasquillo JA; Larson SM; Akhurst TJ
    Nucl Med Commun; 2013 Dec; 34(12):1157-65. PubMed ID: 24100444
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kang L; Li C; Yang Q; Sutherlin L; Wang L; Chen Z; Becker KV; Huo N; Qiu Y; Engle JW; Wang R; He C; Jiang D; Xu X; Cai W
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1470-1481. PubMed ID: 34677626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Evaluation of
    Shi D; Fu W; Tan H; Lin Q; Shi H; Cheng D
    Mol Pharm; 2024 Jan; 21(1):303-312. PubMed ID: 38109713
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.
    Oude Munnink TH; de Vries EG; Vedelaar SR; Timmer-Bosscha H; Schröder CP; Brouwers AH; Lub-de Hooge MN
    Mol Pharm; 2012 Nov; 9(11):2995-3002. PubMed ID: 23003202
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.